HMWO:LSE:LSE-HSBC ETFs Public Limited Company - HSBC MSCI World UCITS ETF (GBX)

ETF | Others |

Last Closing

USD 2847.25

Change

+8.00 (+0.28)%

Market Cap

N/A

Volume

0.05M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-17 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

+2.45 (+0.99%)

USD 292,109.69B
XNIF:LSE Xtrackers Nifty 50 Swap UCITS ..

+82.00 (+0.43%)

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

-2.75 (-1.39%)

USD 1,607.29B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.21 (+1.13%)

USD 701.81B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.09 (+0.64%)

USD 636.56B
0R1I:LSE NVIDIA Corp.

-1.38 (-1.14%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

+1.60 (+2.35%)

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

+0.36 (+1.18%)

USD 260.39B
0QZO:LSE 0QZO

+0.85 (+0.86%)

USD 258.54B

ETFs Containing HMWO:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.81% 20% F 29% F
Dividend Return 0.00% 5% F 4% F
Total Return -4.81% 20% F 29% F
Trailing 12 Months  
Capital Gain 6.47% 54% F 57% F
Dividend Return 0.02% 10% F 8% B-
Total Return 6.48% 51% F 55% F
Trailing 5 Years  
Capital Gain 99.63% 67% D+ 71% C-
Dividend Return 0.13% 14% F 19% F
Total Return 99.76% 64% D 70% C-
Average Annual (5 Year Horizon)  
Capital Gain 12.44% 69% C- 72% C
Dividend Return 12.44% 68% D+ 71% C-
Total Return 0.01% 23% F 15% F
Risk Return Profile  
Volatility (Standard Deviation) 11.05% 64% D 79% B-
Risk Adjusted Return 112.62% 93% A 96% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.